Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy - Concepedia

Concepedia

Publication | Open Access

Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

DOI Full Paper Access

12

Citations

48

References

2020

Year

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda, Oriol Arpí, Maria Martinez‐García, Mar Mallo, Marta Gut, Raquel López-Martos, Sonia Del Barco,

Clinical Cancer Research

Abstract

There is a subset of tumors, frequently classified as mesenchymal or IGS cluster 23, that may be identified with IHC and could well be optimal candidates for immunotherapy.

References

	Year	Citations

Page 1